Article
The Effect of RAS/BRAF Mutation Status on Prognosis and Relapse Pattern in Early Stage Colon Cancers
2023-02-07
Abstract excerpt
<h4>Purpose: </h4> It is known that the RAS and BRAF mutations are predictive for targeted therapies together with chemotherapy in the treatment of metastatic colon cancer and affect negatively the prognosis of the disease. In early stage cancer, however, there are limited studies in the literature about the relationship of this mutational condition with prognosis and relapse pattern of the disease. In this study,...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- d759606a-18fc-57ca-88f5-8f46425c2e63
- DOI
- 10.21203/rs.3.rs-2553560/v1
